ArticleBiochimica et biophysica acta. Molecular cell research2026

Frequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor role.

Evodie Koutouan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.